Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Peter Hillemanns, MD, PhD
Woman Max 99 years
Peter Hillemanns, MD, PhD
Update Il y a 4 ans
Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia
An effective and safe medical therapy would be most welcome to reduce the need for surgical interventions and related adverse events and psychological impact on patients with cervical canc...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Peter Hillemanns, MD, PhD
Update Il y a 4 ans
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
The study will examine the effect of HAL vs placebo photodynamic therapy of low-grade cervical precancerous lesions (dysplasia) in women.
Country
France
,
Germany
,
Norway
organs
None
Specialty
None
Closed trial
More information